Literature DB >> 9390192

Maintenance of transfection rates and physical characterization of lipid/DNA complexes after freeze-drying and rehydration.

T J Anchordoquy1, J F Carpenter, D J Kroll.   

Abstract

It is well established that cationic liposomes form complexes with DNA and effectively transfect cells in vivo and ex vivo. Lipid/DNA complexes have proven safe and nonimmunogenic in clinical trials; however, they are known to aggregate readily in liquid formulations. This physical instability requires clinicians to prepare lipid/DNA complexes immediately prior to injection. In order to eliminate problems associated with this temporal requirement, we investigated the feasibility of preserving complexes as a dried preparation that could be tested, stored, and rehydrated as needed. To this end, our study evaluated the ability of different stabilizers to preserve transfection rates of complexes during acute freeze-drying stress. Our data show that complexes lyophilized in 0.5 M sucrose or trehalose possessed transfection rates similar to those of fresh preparations. In addition, dried complexes that exhibited full transfection activity upon rehydration had sizes comparable to nonlyophilized controls. Our work demonstrates that lipid/DNA complexes can be stabilized as dried powders that offer significant advantages over current liquid formulations. Furthermore, the correlation of transfection rates with maintenance of complex diameter suggests that size plays a critical role in lipid-based DNA delivery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9390192     DOI: 10.1006/abbi.1997.0385

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  12 in total

Review 1.  Improvement of DNA transfection with cationic liposomes.

Authors:  A Rocha; S Ruiz; J M Coll
Journal:  J Physiol Biochem       Date:  2002-03       Impact factor: 4.158

2.  Metal contaminants promote degradation of lipid/DNA complexes during lyophilization.

Authors:  Marion d C Molina; Thomas J Anchordoquy
Journal:  Biochim Biophys Acta       Date:  2006-12-08

3.  Development of a novel method for formulating stable siRNA-loaded lipid particles for in vivo use.

Authors:  Sherry Y Wu; Lisa N Putral; Mingtao Liang; Hsin-I Chang; Nigel M Davies; Nigel A J McMillan
Journal:  Pharm Res       Date:  2008-11-21       Impact factor: 4.200

4.  Excipients for the lyoprotection of MAPKAP kinase 2 inhibitory peptide nano-polyplexes.

Authors:  Alvin J Mukalel; Brian C Evans; Kameron V Kilchrist; Eric A Dailing; Benjamin Burdette; Joyce Cheung-Flynn; Colleen M Brophy; Craig L Duvall
Journal:  J Control Release       Date:  2018-04-27       Impact factor: 9.776

5.  Hyaluronic acid and fibrin hydrogels with concentrated DNA/PEI polyplexes for local gene delivery.

Authors:  Yuguo Lei; Maha Rahim; Quinn Ng; Tatiana Segura
Journal:  J Control Release       Date:  2011-02-02       Impact factor: 9.776

6.  Nerve growth factor expression by PLG-mediated lipofection.

Authors:  Kevin J Whittlesey; Lonnie D Shea
Journal:  Biomaterials       Date:  2005-11-28       Impact factor: 12.479

7.  Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery Systems.

Authors:  Susanne R Youngren-Ortiz; Nishant S Gandhi; Laura España-Serrano; Mahavir B Chougule
Journal:  Kona       Date:  2016-04-30       Impact factor: 2.897

8.  Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury.

Authors:  Laura De Laporte; Anna Lei Yan; Lonnie D Shea
Journal:  Biomaterials       Date:  2009-01-13       Impact factor: 12.479

9.  Effect of lyophilization and freeze-thawing on the stability of siRNA-liposome complexes.

Authors:  Preeti Yadava; Melissa Gibbs; Carlos Castro; Jeffrey A Hughes
Journal:  AAPS PharmSciTech       Date:  2007-12-29       Impact factor: 3.246

10.  Development of a Parenteral Formulation of NTS-Polyplex Nanoparticles for Clinical Purpose.

Authors:  María E Aranda-Barradas; Maripaz Márquez; Liliana Quintanar; Jaime Santoyo-Salazar; Armando J Espadas-Álvarez; Daniel Martínez-Fong; Elizabeth García-García
Journal:  Pharmaceutics       Date:  2018-01-03       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.